Cary W. Sucoff
Cary Sucoff has over 30 years of securities industry experience. Mr. Sucoff currently owns and operates Equity Source Partners, LLC an advisory and consulting firm. He has participated in the financing of hundreds of public and private companies.
Mr. Sucoff currently serves on the following Boards of Directors:
Contrafect Corp., (CFRX), engaged in the development of new treatments for infectious diseases utilizing proprietary antibody and lysin technology;
Legacy Education Alliance, Inc. (LEAI), provides educational training seminars, conferences, and services in the United States, Canada, the United Kingdom, and internationally;
First Wave Technologies, Inc.; brings to the commercial market new and innovative medical device technologies;
Galimedix Therapeutics, Inc. – pursuing small molecule breakthrough licensed from Tel Aviv University working on potentially revolutionary treatments for Glaucoma and Dry Age-related Macular Degeneration.
In addition, Mr. Sucoff currently serves as a consultant to Sapience Therapeutics, Inc., an early stage Biotech company focusing on Glioblastoma.
Mr. Sucoff, a former New York City prosecutor is the Past President of New England Law/Boston and has been a member of its Board of Trustees for over 25 years. He is Chairman of the Endowment Committee.
Mr. Sucoff received a B.A. from SUNY Binghamton (1974) and a J.D. from New England School of Law (1977) where he was the Managing Editor of the Law Review and graduated Magna Cum Laude. Mr. Sucoff has been a member of the Bar of the State of New York (now retired) since 1978.